Essential Guide to the Psychedelic Renaissance

  • "After a very long and strange trip, psychedelics may finally be back for good."
    • —Rick Doblin, PhD, Founder & Executive Director, MAPS.

Psychedelics and Mental Health

  • "Irene de Caso explains in an understandable and entertaining way the current neuroscientific advances related to psychedelic drugs."
    • —José Carlos Bouso, PhD, Scientific Director, ICEERS.

Your Brain on Psychedelics

  • "To understand the pharmacology of psychedelics is to understand the essence of what makes us human."
  • —José Carlos Bouso, PhD, Scientific Director, ICEERS.

Check out our catalogue

  • Discover how psychedelics promote profoundly revealing mental states capable of restructuring our internal models of the world

Recent news

Check out the latest news on the field of psychedelics.

Read more

OHIO UNIVERSITY GETS DEA PERMIT TO PLANT MAGIC MUSHROOMS

By Gabriel García on May 18, 2023

The Ohio State University has become the first U.S. university to obtain a DEA license to grow psychedelic mushrooms. Psychedelic mushrooms, also known as magic mushrooms, are a group of mushrooms that contain psilocybin, a chemical that can alter the perception, mood and cognition of people who consume them. Psilocybin has been used for centuries by various indigenous cultures for ritual, religious and therapeutic purposes, but has also been subject to prohibition and stigma in many countries due to its potential to cause adverse effects and dependence.

More information

Read more

SAM ALTMAN, THE EXECUTIVE BEHIND CHATGPT, IS BETTING ON A REVOLUTION IN PSYCHEDELICS.

By Gabriel García on May 10, 2023

Sam Altman is the executive director of OpenAI, the organization that created ChatGPT, the artificial intelligence chatbot that has gone viral for its witty and funny responses. But Altman not only wants to change the way we communicate with machines, but also the way we treat our mental health and our addictions with psychedelic drugs. Altman is the president of a startup called Journey Colab, which aims to harness the potential that psychedelic drugs have shown in clinical trials and make them accessible to people suffering from mental health and substance use disorders.

More information

Read more

What is SB 519, or how psychedelics could come to California

By Gabriel García on May 3, 2023

California is one of the most progressive states in the United States in terms of drug policy reform. In recent years, several California cities have decriminalized the use and cultivation of psychedelic plants and mushrooms, including Oakland, Santa Cruz and Berkeley. In addition, there is a state bill that seeks to decriminalize the possession and exchange of small amounts of seven psychedelic substances, including psilocybin, LSD and MDMA, for people over the age of 21.

More information

Read more

A postgraduate program on the clinical application of psychedelics has been launched by a UK university

By Gabriel García on April 26, 2023

The University of Exeter in the United Kingdom has announced the launch of a postgraduate course in the clinical use of psychedelics, the first of its kind in Europe. The course, which will begin in September 2023, aims to train mental health professionals in the therapeutic use of substances such as LSD, psilocybin or MDMA, which have been shown to be effective in the treatment of disorders such as depression, post-traumatic stress disorder or addiction.

More information